Journal of Dermatological Treatment

Papers
(The H4-Index of Journal of Dermatological Treatment is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis69
The hf-PGA is a valid and reliable measure of hand/foot psoriasis severity in adults: results from a phase 2b clinical trial68
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Pso59
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participants53
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa47
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy45
Lessons from a decentralized trial in atopic dermatitis: promises and perils40
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Regist40
Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial38
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)36
Topical delgocitinib for the treatment of chronic hand eczema34
Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits30
A systematic review of recent randomized controlled trials for palmoplantar pustulosis29
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab27
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most25
Skin type classifications: does the perfect assessment exist?25
Unmet needs in atopic dermatitis management: an expert consensus23
Driving taxis23
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks23
Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis22
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study21
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses21
Long-Term efficacy and safety analysis of secukinumab in the treatment of pediatric generalized pustular psoriasis: a real-world study21
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years21
0.31284403800964